Vascular Guidewires
A Global Strategic Business Report
MCP15454
RESEARCH TRANSCRIPTS | |
---|---|
#ChatsWithChaudhrey Anil Busimi, GMD, Terumo Pharmaceutical Solutions, Injectable Drug delivery,
MY SILO
DESCRIPTION:
I sat down with Anil a couple of months ago to discuss the trends and challenges in injectable drug delivery, We discussed .... Terumo's background, and Anil's background 01:10 What were the challenges Anil faced joining a business in a senior role virtually during lockdown? 04:30 How did the pandemic impact how Terumo looked after their customers 05.60 What were the new ways Terumo were dealing with their customers digitally 08:08 What does Anil see as the main trends in injectable drug delivery? 09:56 What did Anil think about the use of digital devices in medical devices? 15:49 How is sustainability impacting the design and packaging of delivery devices? 18:54 What are the main challenges in injectable drug delivery 21:08 Feel free to leave Anil any comments and questions below. You can find out more about Terumo at their brand new website www.terumopharmaceuticalsolutions.com You can also see Terumo Pharmaceutical Solutions At CPHI WW Milan. See you there! #DrugDevices, #MedicalDevices, #Injectables, #PreFilledSynringes, #PFS
TRANSCRIPT:
|
|
CPhI Worldwide 2019 | Interview with Terumo
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
Terumo BCT Presents: Harvest Technologies in Azerbaijan (Part 1)
MY SILO
DESCRIPTION:
Harvest Event hosted in Baku Thalassemia Center in Azerbaijan on January 17th, 2019.
TRANSCRIPT:
|
|
Beyond Biotech podcast 31: Orgenesis, Phacilitate, Terumo, University of Birmingham, VIVEBiotech
MY SILO
DESCRIPTION:
01:22 Labiotech.eu news 03:03 Phacilitate/Advanced Therapies Week 14:15 Orgenesis 25:18 Terumo 31:47 VIVEBiotech 38:33 University of Birmingham Phacilitate’s Advanced Therapies Week took place last week in Miami Beach, Florida. This week, we speak with the organizers, as well as some of the companies in attendance. Our guests are Kim Barnes, EVP, Phacilitate; Kathie Schneider, director and global commercial lead at Terumo; Vered Caplan, CEO, Orgenesis; Ivan Wall, head of the Centre for Advanced Therapies Manufacturing Training, University of Birmingham; and Natalia Elizalde, business development director, VIVEBiotech. ➡ Listen to all Beyond Biotech episodes here: https://www.youtube.com/playlist?list... ➡ Subscribe to our newsletter: https://bit.ly/3kHyfKc ➡ Get more biotech news: Official site: https://bit.ly/3OJgYzi Linkedin: https://www.linkedin.com/company/5312453 Twitter: https://twitter.com/Labiotech_eu Facebook: https://www.facebook.com/Labiotech.eu Instagram: https://www.instagram.com/labiotech.eu/ About Labiotech.eu: Labiotech.eu is an online publication covering the global biotech industry, with a mix of news and in-depth analysis. Updated daily, the site also includes a weekly podcast. About Beyond Biotech: Beyond Biotech is a weekly podcast from Labiotech.eu. Each episode - intended to entertain and inform - features news, and several guests on a variety of current topics. #biotech #biotechnology #podcast
TRANSCRIPT:
|
|
Terumo Corporation Contributing to Society through Healthcare
MY SILO
DESCRIPTION:
Video Corporativo da Terumo 2021 | 2022
TRANSCRIPT:
|
|
Terumo Medical do Brasil | Evento Brasilidades
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
Terumo Virtual KICK-OFF Meeting
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
EBC 2021- TERUMO SESSION: MASTERING POT WITH ULTIMASTER STENT
MY SILO
DESCRIPTION:
European Bifurcation Club 2021 - DAY 2 TERUMO SYMPOSIUM: MASTERING POT WITH ULTIMASTER STENT Chat master: Gabor Toth Chair: Thierry Lefevre Panel: Bernard Chevalier, Dejan Milasinovic, Tom Johnson 6' + 2' Latest e-ULTIMASTER data for POT - Dr Bernard Chevalier 6' + 3' POT in bench model with Ultimaster Tansei stent - Dr Dejan Milasinovic 8' + 5' Clinical case discussion - Dr Tom Johnson
TRANSCRIPT:
|
|
What is Terumo Blood and Cell Technologies
MY SILO
DESCRIPTION:
Terumo Blood and Cell Technologies is at the forefront of advancing medical technologies and solutions in the fields of blood management and cell therapy. In this enlightening video, we explore the groundbreaking innovations and contributions made by Terumo Blood and Cell Technologies in improving patient outcomes and transforming healthcare. We'll explore the importance of blood component optimization, precision medicine, and the integration of data-driven solutions to enhance transfusion practices. Learn how Terumo Blood and Cell Technologies are paving the way for improved patient safety, reduced transfusion risks, and more efficient blood management in healthcare settings. #nursing #bloodtransfusion #terumo #nursingstudent #travelnurse Cup of Nurses: https://fanlink.to/CONsite Frontline Warriors: https://fanlink.to/FWsite Apple https://fanlink.to/Applepodcast Spotify https://fanlink.to/Spotifypodcast Cup of Nurses Store https://fanlink.to/CONshop Frontline Warriors store https://fanlink.to/FWshop Interested in Travel Nursing? https://fanlink.to/TravelNurseNow Free Travel Nursing Guide https://fanlink.to/Travelnursingchecklist Nclex Guide https://fanlink.to/NCLEXguide Cup of Nurses FB Group https://www.facebook.com/groups/cupofnurses Frontline Warriors FB group https://fanlink.to/FWFBgroup
TRANSCRIPT:
|
|
Terumo Medical Care Solutions (2022)
MY SILO
DESCRIPTION:
In April 2022, Terumo Corporation announced a new business brand, Terumo Medical Care Solutions. This video introduces the Terumo Medical Care Solutions brand, with the brand promise "Quality time for better care," which aims to create "quality time" for everyone involved in healthcare. Terumo Medical Care Solutions brand site https://tmcs.terumo.com/en/ (C) Terumo Corporation 2022
TRANSCRIPT:
|
|
Terumo Cardiovascular Group Profile
MY SILO
DESCRIPTION:
Leaders at Terumo Cardiovascular Group describe how they achieved zero workmanship issues in 12 months. Camstar's eDHR enables Terumo Cardiovascular Group associates to stay firmly focused on product quality. Hear directly from Terumo Operations, Manufacturing Engineering and Quality Management how their manufacturing organization has error-proofed processes, enabled proactive process improvement, reduced nonconformances, continuously improved lean operations -- and help save 1,000 lives every day.
TRANSCRIPT:
|
|
PREMIACIÓN NIPRO MEDICAL CORPORATION SUCURSAL DEL PERÚ 2015
MY SILO
DESCRIPTION:
TRANSCRIPT:
|
|
Basics of Dialysis - Nipro Medical India
MY SILO
DESCRIPTION:
Gentle and painless Hemodialysis to ensure sparkling health with superior performance guaranteed by advance Japanese technologies. Nipro Renal Care presents ultramodern dialysis units with the latest and advanced Japanese technologies, following international guidelines to provide the best quality dialysis at an affordable price, with over 5 decades of experience in providing renal solutions for dialysis and dialysis-related treatment. We specialize in developing dialysis machines, water treatment systems, and a comprehensive portfolio of disposable medical equipment. Our dialysis machines provide Optimal Treatment, Quality, and Safety; they are reliable and user friendly, facilitating the staff to work efficiently with high accuracy. Offering various therapies such as: HDF, Sled, CRRT, High Flux Dialysis, ICU Dialysis and Home HD. Nipro Renal Care is driven by innovation and patient safety to offer the highest quality products that optimize time, effort, and costs. BECAUSE EVERY LIFE DESERVES AFFORDABLE CARE #nipro #dialysis #hemodialysis #kidneydisease #wearenipro #LiveLongerLiveBetter #yourpartnerinhealthcare #kidneyfailure #chronickidneydisease #dialysislife #dialysispatient #Renalcare
TRANSCRIPT:
|
|
Symposium sponsored by FRESENIUS MEDICAL CARE
MY SILO
DESCRIPTION:
Anticoagulation in CRRT: State-of-the-art in 2020
TRANSCRIPT:
|
|
Len Usvyat, Fresenius Medical Care - Roadmap to Success in Data and Analytics | Corinium
MY SILO
DESCRIPTION:
In this riveting conversation with Len Usvyat, Vice President, Integrated Care Analytics at Fresenius Medical Care North America, he shared excellent points as we unravel the roadmap to success in data and analytics. He is one of the more than 200 Chief Analytics Officers, Data Leaders, Senior Analytics Experts and Innovators who gathered in New York on October 5-7 for a three-day “Chief Analytics Officer, Fall” conference filled with networking, high level insight and discussion, addressing the hottest topics and challenges faced by CAOs and Senior Data & Analytics professionals. Organised by Corinium, the leading conferences and content producer for the emerging C-suite executives focused on Data, Analytics, Customer and Digital Innovation, this event sets the pace of innovation and disruption in today’s digital landscape. In 2016, Corinium welcomed 3,500 attendees in its conferences – 40% of which were C-Suite, President or Vice President Level. Corinium’s previous participants share their remarkable experience: “The conference was a fantastic way to connect with professionals leading the Data & Analytics transformation in the industry.” - Jessica Rusu, Director EU Analytics, eBay "It has been a great pleasure attending the CDO Forum and I caught some very interesting insights from the many different sessions" - Fabrice Otano, SVP, Chief Data Officer, Accor It was a great cross sectoral event. It was a unique opportunity to share knowledge and build networks with CDOs form the most valuable brands.” - Eduard Gil, Chief Data Officer, SAGESSA “We all learn differently...and this format [discussion groups] let's us learn by participating. And that is the thing we will remember. It's personal.” - Dipti Patel, Chief Data and Analytics Officer, CEP America 'It really takes the coming together of people like these [Attendees of the Chief Analytics Officer Fall]...to tell us, this is the problem we need to come together to solve' - John Sullivan, Director of Innovation, North America Center of Excellence, SAP 'I think the interactions here are much better than...the other conferences I have ever attend' - Oliver Halter, Partner, PwC 'The people at the Corinium events are the decision-makers and are the people that push the industry forward. If that benefits the industry, great. If that benefits us too, also great." - Romi Mahajan, Chief Commercial Officer, TimeXtender
TRANSCRIPT:
|
|
Symposium sponsored by FRESENIUS MEDICAL CARE
MY SILO
DESCRIPTION:
Extracorporeal Pathogen Adsorbtion in the critically ill patients. Is it the time for a different approach?
TRANSCRIPT:
|
|
Dialyse & Xenotransplantation - Dr. Martin Pachmann (Fresenius Medical Care)
MY SILO
DESCRIPTION:
@freseniusmedicalcare (FMC) ist der weltweit führende Anbieter von Produkten und Dienstleistungen für Menschen mit Nierenerkrankungen, von denen sich weltweit rund 3,4 Millionen Patienten regelmäßig einer Dialysebehandlung unterziehen. Mit seinem Netzwerk von 4.003 Dialysekliniken versorgt Fresenius Medical Care 342.488 Patienten rund um den Globus. Das Unternehmen ist weltweit der einzige Komplettanbieter innovativer Therapien und Produkte für nierenkranke Menschen. Wir sprechen mit Dr. Martin Pachmann, Medical Director bei der Fresenius Group, über die Entwicklung des Unternehmens, zunehmenden Möglichkeiten für eine #Dialyse zu Hause, über Fragen der Nachhaltigkeit bis zu digitalen Lösungen und der #Xenotransplantation. Mehr Informationen finden Sie hier: https://www.freseniusmedicalcare.com/de/startseite #businesstalk #interview #dialysis
TRANSCRIPT:
|
|
Fresenius Medical Care Aktie Analyse - Weltmarktführer! | Aktienanalyse (inkl. Fairer Preis)
MY SILO
DESCRIPTION:
Im heutigen Video geht es um "Fresenius Medical Care". Wir haben dieses Unternehmen unter Berücksichtigung von quantitativen sowie qualitativen Aspekten analysiert; am Ende sogar noch den “Fairen Wert” berechnet. Die reinen Zahlen, Daten und Fakten auszuwerten, ist sehr wichtig und auch hilfreich für die Erkenntnisgewinnung, die qualitative Betrachtung eines Unternehmens, also aus einer ganz anderen Perspektive, nämlich durch die “Brille eines Verbrauchers” aber auch! Wir hoffen, dass euch unsere Aktienanalyse gefällt! Was haltet ihr von Fresenius Medical Care? Seid ihr in Fresenius Medical Care investiert? Schreibt es gerne in die Kommentare! Hier geht es zur Analyse der Fresenius SE & Co. KGaA: https://www.youtube.com/watch?v=Kp-z9cpYV1g Bitte, bitte, bitte, gebt uns auch Feedback! Sagt was wir besser machen können und wie wir die Qualität unserer Inhalte noch mehr steigern können! Daher freuen wir uns über jede konstruktive Kritik! #FreseniusMedicalCare #AktienAnalyse #FairerPreis Das Team von Rational Investieren :D Timestamps: 0:00 Intro 0:17 Unternehmensvorstellung 0:43 Historie 2:08 Aktionärsstruktur 2:33 Kursverlauf der Aktie 2:55 Umsatz & Gewinn - Entwicklung 3:15 Durchgeführte Behandlungen 3:25 Entwicklung der Dialysekliniken 3:36 Umsatz - Segmente & Regionen 4:16 Sortiment & Produkte 4:40 Dividendenentwicklung 4:55 Ausschüttungsquote 5:30 Verschuldung 6:05 Rentabilität & Kennzahlen des operativen Geschäfts 6:31 Burggraben 7:02 Wissenswertes 7:21 Wettbewerber 7:55 Zusammenfassung 8:18 Dividendenerwartung 9:09 Historische Bewertung 9:32 Renditeerwartungen & Fairer Wert 10:10 Fairer Preis nach Bewertungsmethoden 📸 INSTAGRAM: https://www.instagram.com/rational.investieren/?hl=de ⚠ Disclaimer: Alle Angaben und Berechnungen wurden nach bestem Wissen erstellt sowie nach bestem Wissen und Gewissen überprüft, jedoch wird KEINE Gewähr auf Vollständigkeit und Richtigkeit übernommen Es handelt sich um KEINE Anlageberatung; es wird weder zum Kauf oder Verkauf eines Finanzproduktes aufgefordert; Alle Inhalte basieren auf unserer Meinung Die Inhalte dienen lediglich zu Informationszwecken (Möglicherweise) Werbung aufgrund von Markennennung
TRANSCRIPT:
|